BEBIG Medical

What BEBIG Medical does

BEBIG Medical GmbH is a Berlin-based, privately held manufacturer and global distributor of radiation therapy medical devices for cancer treatment. Founded in 1970 (per company history) and registered as a GmbH, the company reports more than 50 years of clinical experience and an active installed base of over 1,000 systems across more than 90 countries. Its product portfolio covers four principal modalities: linear accelerators (SagiStar LINAC, co-developed with RaySearch), high-dose-rate brachytherapy (SagiNova afterloader with SagiPlan treatment planning software), intraoperative radiation therapy (WOmed ioRT-50), and superficial/orthovoltage X-ray therapy (WOmed T-105, WOmed T-200), alongside consumables and accessories including HDR applicators, Co-60 radioactive sources, prostate LDR brachytherapy products, and quality assurance tools such as RadControl II.

The company monetizes through one-time capital equipment sales to hospitals and cancer treatment centers, recurring revenue from consumables tied to the installed base, and ongoing service and maintenance contracts. Go-to-market combines direct regional offices in Europe, the United States, and Asia with a network of more than 90 distributors, supplemented by active participation in major radiation oncology conferences (ESTRO, ASTRO, DEGRO, SFRO, ICARO). The company holds EU MDR certification for the WOmed T-105 and CE certification for its linear accelerator, and positions itself as a comprehensive, mid-tier alternative serving both developed and emerging markets.

Primary end customers are hospitals, cancer treatment centers, and dermatology/skin cancer clinics; named end customers in the available data are limited to the recently announced Philippine deployments. The company is privately held with no disclosed institutional investors, no venture funding rounds identified, and no parent company; recent operational expansion has been driven by a wholly-owned Philippines subsidiary opened in January 2026. Leadership comprises George Chan (CEO) and Chan Hwang Tong (Managing Director), supported by regional management for the new Southeast Asia operations.

Name

BEBIG Medical

Legal name

BEBIG Medical GmbH

Website

https://bebigmedical.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

51–100 employees

Short description

BEBIG Medical GmbH is a Berlin-based manufacturer of radiation therapy devices — linear accelerators, HDR brachytherapy systems, intraoperative RT, and X-ray therapy systems — serving hospitals and cancer treatment centers across 90+ countries through direct offices and a 90+ distributor network.

Ownership category

akta.pro rank

Product category

Radiation Therapy Medical Devices

NAICS

Irradiation Apparatus Manufacturing (334517), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industry

Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology) (EUAKAIAD)

Keywords

• Radiation therapy devices
• Brachytherapy systems
• Linear accelerators
• Intraoperative radiation therapy
• X-ray therapy systems

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of radiation therapy equipment including linear accelerators, brachytherapy systems, X-ray therapy units, and intraoperative radiation therapy devices to hospitals and cancer treatment centers
2. Accessories and Consumables: Sale of HDR applicators, radioactive sources (Co-60), and radiotherapy accessories for use with main equipment
3. Service and Support: Ongoing service, maintenance, and clinical support services for installed base

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

BEBIG Medical manufactures and globally distributes radiation therapy medical devices for cancer treatment, organized into four product pillars: Linear Accelerators (SagiStar), High-Dose-Rate Brachytherapy systems (SagiNova Afterloader and SagiPlan Treatment Planning System), Intraoperative Radiation Therapy (WOmed ioRT-50), and X-Ray Therapy (WOmed T-105 and T-200). The portfolio is complemented by accessories and consumables including HDR applicators, Co-60 radioactive sources, prostate LDR brachytherapy products, radiotherapy accessories, and quality assurance tools sold to hospitals, cancer centers, and dermatology clinics in over 90 countries.

Product overview

BEBIG Medical GmbH is a global provider of radiation therapy medical devices offering a comprehensive portfolio of products organized into four main categories: Linear Accelerators (including the SagiStar LINAC), High-Dose-Rate (HDR) Brachytherapy systems (featuring the SagiNova® Afterloader and SagiPlan® Treatment Planning System), X-Ray Therapy products (WOmed T-105 and T-200), and Intraoperative Radiation Therapy devices (WOmed ioRT-50). The portfolio also includes a wide range of accessories including HDR applicators, radioactive sources, prostate LDR brachytherapy products, and quality assurance tools. The company serves over 90 countries with more than 1,000 active installations worldwide, supported by a network of over 90 global distributors.

Differentiator

Problem solved

Functional benefit

Brands

• SagiNova: HDR (High-Dose-Rate) brachytherapy afterloader system for cancer treatment
• SagiPlan
• SagiStar
• WOmed
• RadControl II

Products and services

• SagiStar Linear Accelerator Linear accelerator (LINAC) for external beam radiotherapy, offering modern radiation therapy technology for cancer treatment, developed in collaboration with RaySearch. Sold to hospitals and cancer centers.
• SagiNova HDR Afterloader High-dose-rate (HDR) brachytherapy afterloader for precise internal radiation therapy treatment delivery to tumors, used by hospitals and radiotherapy centers performing brachytherapy procedures.
• SagiPlan TPS Treatment Planning System (TPS) for brachytherapy treatment planning and dose calculation, used by radiation oncology clinical teams designing HDR brachytherapy procedures.
• WOmed ioRT-50 Intraoperative Radiation Therapy (IORT) system for delivering radiation treatment during surgery, used by surgical oncology teams needing precise in-operating-room radiation delivery.
• WOmed T-105 X-ray therapy system certified under European Medical Device Regulation (MDR) for superficial radiation therapy treatments, used by dermatology and oncology clinics treating skin cancer.
• WOmed T-200 X-ray therapy system for superficial and orthovoltage radiation therapy treatments, used by dermatology centers and oncology facilities for skin cancer and superficial lesion treatment.
• Radioactive Sources (Co-60) Cobalt-60 radioactive sources for brachytherapy treatments, supplied as consumables to brachytherapy programs operating SagiNova and other HDR afterloaders.
• HDR Applicators Applicators and templates for high-dose-rate brachytherapy procedures, including CTMR-compatible sets for gynecological treatments, used by radiotherapy clinical teams alongside the SagiNova afterloader.
• ioRT-50 Applicator Applicators designed for use with the WOmed ioRT-50 intraoperative radiation therapy system, supplied as procedure-specific consumables to surgical oncology teams.
• Prostate LDR Brachytherapy Low-dose-rate brachytherapy products for prostate cancer treatment, supplied to urology and radiation oncology centers performing permanent seed prostate brachytherapy.
• RadControl II Radiation control device for therapy systems providing radiotherapy control and quality assurance functions, used by medical physicists for verification and validation of radiotherapy systems.
• Quality Assurance Tools Quality assurance equipment for verifying and validating radiotherapy systems, used by medical physics teams as part of routine clinical quality assurance programs.

Quantifiable outcome

• 1000+ active installations globally
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered regional and core.

• Philippine Oncology Center Corp.regionalChannel Partner/ Reseller/ Distributor · 23 January 2026Collaboration for first SagiStar LINAC installation in the Philippines at St. Paul Hospital Tuguegarao. Philippine Oncology Center Corp. serves as the local distribution and implementation partner expanding access to advanced cancer care in Northern Luzon.
• St. Paul Hospital TuguegaraoregionalStrategic or Co-development Partner · 23 January 2026Installation of first SagiStar linear accelerator in the Philippines, expanding modern radiotherapy access to patients in Northern Luzon region. Represents company's commitment to improving geographic access to cancer care.
• uniteRTcoreTechnology or Integration · 13 May 2023BEBIG Medical joined uniteRT as a member at ESTRO 2023, marking a meaningful step in advancing open, integrated solutions in radiation therapy. The collaboration focuses on promoting interoperability and integration standards in radiation therapy technology.
• RaySearchcoreTechnology or IntegrationCollaborative innovation partnership resulting in the SagiStar linear accelerator. BEBIG Medical and RaySearch jointly developed and presented SagiStar, combining BEBIG's hardware expertise with RaySearch's treatment planning software for integrated radiotherapy solutions.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Others

• CIVCO Radiotherapy: US-headquartered supplier of radiotherapy accessories, immobilization, and surface-guided radiotherapy tools. Sits in BEBIG's ecosystem as a competitor in the radiotherapy accessories and consumables category adjacent to BEBIG's applicator and accessory franchises.
• RaySearch Laboratories: Swedish treatment planning software (RayStation, RayCare) vendor and BEBIG's named SagiStar co-development partner. Enables BEBIG's LINAC story; however it also sells competing TPS/engine products to other LINAC OEMs, making it a strategic ecosystem participant rather than head-to-head equipment rival.

Direct peers

• Elekta: Swedish-headquartered radiation oncology vendor with linear accelerators (Versa HD, Unity), HDR brachytherapy (Flexitron), and oncology software. Elekta competes most directly with BEBIG across LINAC and brachytherapy product lines for the same hospital and cancer-center customers.
• IntraOp Medical Corporation: Specialist in intraoperative radiation therapy (IORT) with the Mobetron system. The closest direct peer to BEBIG's WOmed ioRT-50, competing in the same surgical-oncology and breast-cancer IORT workflows.
• Best Medical International / Best Theratronics: US/Canadian group selling brachytherapy systems (Ir-192 afterloaders), Co-60 external-beam therapy units, and superficial/orthovoltage X-ray therapy systems. Direct peer in orthovoltage X-ray therapy (vs WOmed T-105/T-200) and in HDR/LDR brachytherapy equipment.
• Eckert & Ziegler Strahlen- und Medizintechnik AG: Berlin-based supplier of brachytherapy seeds, radioactive sources, and radiopharmaceutical products. Overlaps with BEBIG's Co-60 source and prostate LDR brachytherapy franchises, serving shared oncology customers.
• Accuray Incorporated: US-based radiotherapy vendor selling the CyberKnife and TomoTherapy/Helical systems for stereotactic and image-guided radiotherapy. Direct competitor in advanced external-beam radiotherapy for hospitals evaluating alternatives to conventional LINACs.

Broad incumbents

• Varian Medical Systems (Siemens Healthineers): Now operating within Siemens Healthineers, Varian is the market-leading radiation oncology platform with TrueBeam/Ethos LINACs, brachytherapy (GammaMedPlus), and the full ARIA oncology IT stack. The dominant incumbent BEBIG most often competes against in capital-equipment tenders.

Emerging players

• ViewRay Inc. Developer of MRIdian MR-guided LINAC systems combining imaging and radiation delivery. Direct clinical-overlap competitor targeting the same adaptive radiotherapy conversations in academic centers, though operating with a specialized MR-LINAC niche.
• Mevion Medical Systems: US-based proton therapy system vendor (MEVION S250i/Hyperscan) selling compact single-room proton systems. Competes for the same radiation oncology capital budget, particularly at mid-sized cancer centers considering particle therapy alternatives to conventional LINACs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCmN5J1NcyECqO5-IYJ60dyA
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/bebig-medical

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BEBIG Medical